Clinical significance of estrogen receptors in human breast cancer.
D000315:Adrenalectomy; D000818:Animals; D001940:Breast / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D002369:Castration; D002467:Cell Nucleus / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004958:Estradiol / Q000378:metabolism; D004965:Estrogen Antagonists; D004967:Estrogens / Q000378:metabolism* / Q000627:therapeutic use; D006727:Hormone Antagonists / Q000627:therapeutic use; D006801:Humans; D007016:Hypophysectomy; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D011485:Protein Binding; D011869:Radioligand Assay; D051381:Rats; D011956:Receptors, Cell Surface; D014316:Tritium
D004965:Estrogen Antagonists; D004967:Estrogens; D006727:Hormone Antagonists; D011956:Receptors, Cell Surface; D014316:Tritium; D004958:Estradiol; D011241:Prednisone